The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis
…, P Harnett, S Krausze, S Steddon - Nephrology Dialysis …, 2009 - academic.oup.com
Background. Encapsulating peritoneal sclerosis (EPS) is a disease process that can occur
as a complication of peritoneal dialysis (PD). The aim of this study was to make a general …
as a complication of peritoneal dialysis (PD). The aim of this study was to make a general …
Calcimimetics and calcilytics—fooling the calcium receptor
SJ Steddon, J Cunningham - The Lancet, 2005 - thelancet.com
Context Just a decade after the the calcium-sensing receptor (CaR) was identified,
pharmacological manipulation of the CaR is about to enter routine practice. For hyperparathyroid …
pharmacological manipulation of the CaR is about to enter routine practice. For hyperparathyroid …
[BOOK][B] Oxford handbook of nephrology and hypertension
S Steddon, A Chesser, N Ashman - 2014 - books.google.com
Fully revised and expanded for its second edition, the Oxford Handbook of Nephrology and
Hypertension provides clear, concise information and practical guidance on the day-to-day …
Hypertension provides clear, concise information and practical guidance on the day-to-day …
Vitamin D analogues: how do they differ and what is their clinical role?
SJ Steddon, NJ Schroeder… - Nephrology Dialysis …, 2001 - academic.oup.com
The development of vitamin D analogues capable of effective parathyroid suppression whilst
avoiding undesirable low bone turnover, hypercalcaemia and hyperphosphataemia has …
avoiding undesirable low bone turnover, hypercalcaemia and hyperphosphataemia has …
Summary of the 5th edition of the Renal Association Clinical Practice Guidelines (2009–2012)
…, B Shrestha, R Shrivastava, S Steddon… - Nephron Clinical …, 2011 - karger.com
… Simon Davies … Simon Steddon; Simon Steddon …
New prospects for the management of renal bone disease
SJ Steddon, SLS Fan, J Cunningham - Nephron Clinical Practice, 2005 - karger.com
The last decade has been a remarkably productive one in the field of bone biology. New
insights into the maintenance of a normal bone microenvironment have led to significant …
insights into the maintenance of a normal bone microenvironment have led to significant …
Renal Association Clinical Practice Guideline in mineral and bone disorders in CKD
S Steddon, E Sharples - Nephron, 2011 - karger.com
… Dr Simon Steddon and Dr Edward Sharples Email: Dr Simon Steddon at Simon.Steddon@gstt.nhs.uk
or Dr Edward Sharples at Edward.Sharples@orh.nhs.uk … Dr Simon Steddon has no …
or Dr Edward Sharples at Edward.Sharples@orh.nhs.uk … Dr Simon Steddon has no …
Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu
SJ Steddon, CW McIntyre, NJ Schroeder… - Nephrology Dialysis …, 2004 - academic.oup.com
Background. Osteoblast-derived interleukin-6 (IL-6) affects bone metabolism and is linked
with a number of pathological states characterized by increased bone resorption, including …
with a number of pathological states characterized by increased bone resorption, including …
[HTML][HTML] Supporting a hospital in difficulty: experience of a 'buddying'agreement to implement a new medical pathway
…, A Waterman, J Parrott, J Gifford, S Steddon… - Future Healthcare …, 2019 - ncbi.nlm.nih.gov
Increased NHS regulation has identified many healthcare organisations with operational
and/or financial difficulties. Although the causes are often complex, most cases are effectively …
and/or financial difficulties. Although the causes are often complex, most cases are effectively …
Case report: making the CONN-ection: two cases of persistent hypertension and hypokalaemia following renal transplantation
A Kumar, J Hubbard, M Moonim, S Steddon… - … urology and nephrology, 2012 - Springer
Conn’s syndrome following renal transplantation is extremely rare. Here, we present two
cases of persistent hypertension and hypokalemia, emerging after kidney transplantation, …
cases of persistent hypertension and hypokalemia, emerging after kidney transplantation, …